Epicore Biosystems

Epicore Biosystems develops sweat-sensing wearable technology for real-time health and hydration monitoring. The company's proprietary microfluidic sensing platform analyzes small droplets of sweat directly from the skin, measuring biomarkers including electrolytes, metabolites, nutrients, proteins, and toxins. Epicore offers solutions across three verticals: industrial safety (real-time hydration interventions for workers), sports and fitness (personalized hydration and performance feedback), and clinical research (FDA-registered, non-invasive sweat collection and extraction system for laboratory-grade biomarker analysis). The platform combines sweat analysis with skin temperature and motion data to provide comprehensive physiological insights. The company's research has been published in top peer-reviewed journals. Founded in 2017 and headquartered in Cambridge, Massachusetts, Epicore Biosystems has raised $43.9M in Series B funding from investors including Joyance Partners, Alumni Ventures, Chevron, Pegasus Tech Ventures, and Reform Ventures.